Big #disruptions are hitting #ObesityCare. They're uncomfortable and will get even more so. Along the way hazards will pop up, like #CompoundedSemaglutide. The U.S. Food and Drug Administration and pharma companies like Novo Nordisk and Eli Lilly and Company must get this right.
https://conscienhealth.org/2023/06/disruption-discomfort-and-hazards-in-obesity/